{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:05:30Z","timestamp":1785942330321,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY027476"],"award-info":[{"award-number":["R01 EY027476"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Racemic vigabatrin","award":["VU30118553"],"award-info":[{"award-number":["VU30118553"]}]},{"name":"Vanderbilt Institute of Chemical Biology, Chemical Synthesis Core, Vanderbilt, University, Nashville","award":["37232-0412"],"award-info":[{"award-number":["37232-0412"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.neuint.2019.02.015","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T02:32:57Z","timestamp":1551148377000},"page":"151-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Metabolomic analyses of vigabatrin (VGB)-treated mice: GABA-transaminase inhibition significantly alters amino acid profiles in murine neural and non-neural tissues"],"prefix":"10.1016","volume":"125","author":[{"given":"Dana C.","family":"Walters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erland","family":"Arning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodoro","family":"Bottiglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin E.W.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajja S.","family":"Salomons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalyn N.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett R.","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Roullet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2019.02.015_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0197-0186(03)00135-9","article-title":"Vigabatrin inhibits pyridoxine-5'-phosphate oxidase, not pyridoxal kinase in the hippocampus of seizure prone gerbils","volume":"44","author":"An","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2019.02.015_bib2","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1113\/JP272050","article-title":"Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by \u03b2-alanine transamination","volume":"594","author":"Blancquaert","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuint.2019.02.015_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1152\/jn.1985.53.3.699","article-title":"Roles of aspartate and glutamate in synaptic transmission in rabbit retina. I. Outer plexiform layer","volume":"53","author":"Bloomfield","year":"1985","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuint.2019.02.015_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1350-9462(00)00031-8","article-title":"Rod vision: pathways and processing in the mammalian retina","volume":"20","author":"Bloomfield","year":"2001","journal-title":"Prog. Retin. Eye Res."},{"issue":"4S Suppl. l","key":"10.1016\/j.neuint.2019.02.015_bib5","doi-asserted-by":"crossref","first-page":"988S","DOI":"10.1093\/jn\/130.4.988S","article-title":"Glutamate, at the interface between amino acid and carbohydrate metabolism","volume":"130","author":"Brosnan","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.neuint.2019.02.015_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1006947322342","article-title":"The glio-toxic mechanism of alpha-aminoadipic acid on cultured astrocytes","volume":"27","author":"Brown","year":"1998","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.neuint.2019.02.015_bib7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ajhg.2012.10.006","article-title":"DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria","volume":"91","author":"Danhauser","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuint.2019.02.015_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1471-4159.2009.06368.x","article-title":"Mechanism of the persistent sodium current activator veratridine-evoked Ca elevation: implication for epilepsy","volume":"111","author":"Fekete","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2019.02.015_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.reprotox.2016.11.002","article-title":"Involvement of l-type amino acid transporter 1 in the transport of gabapentin into human placental choriocarcinoma cells","volume":"67","author":"Furugen","year":"2017","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.neuint.2019.02.015_bib10","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00726-012-1273-3","article-title":"Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells","volume":"43","author":"Gaucher","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuint.2019.02.015_bib11","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/0024-3205(81)90511-7","article-title":"Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid)","volume":"28","author":"Grove","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2019.02.015_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1113\/jphysiol.2014.283432","article-title":"Dynamic regulation of D-serine release in the vertebrate retina","volume":"593","author":"Gustafson","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuint.2019.02.015_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1475-1313.2002.00063.x","article-title":"Neurotoxic effects of GABA-transaminase inhibitors in the treatment of epilepsy: ocular perfusion and visual performance","volume":"22","author":"Hosking","year":"2002","journal-title":"Ophthalmic Physiol. Optic."},{"key":"10.1016\/j.neuint.2019.02.015_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.09.016","article-title":"High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex","volume":"148","author":"Hussain","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuint.2019.02.015_bib15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbadis.2006.01.006","article-title":"Increased guanidino species in murine and human succinate semialdehyde dehydrogenase (SSADH) deficiency","volume":"1762","author":"Jansen","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2019.02.015_bib101","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-213X-8-112","article-title":"Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development","volume":"8","author":"Jansen","year":"2008","journal-title":"BMC Dev Biol."},{"key":"10.1016\/j.neuint.2019.02.015_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s13311-014-0266-1","article-title":"The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments","volume":"11","author":"Kaminski","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuint.2019.02.015_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-4835(82)80055-9","article-title":"Toxic effects of DL-alpha-aminoadipic acid on m\u00fcller cells from rats in vivo and cultured cerebral astrocytes","volume":"35","author":"Karlsen","year":"1982","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.neuint.2019.02.015_bib18","first-page":"19","article-title":"Mechanism of the DL-alpha-aminoadipic acid inhibitory effect on form-deprived myopia in Guinea pig","volume":"6","author":"Mao","year":"2013","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.neuint.2019.02.015_bib19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4155\/tde.14.55","article-title":"Pharmacokinetic aspects of the anti-epileptic drug substance vigabatrin: focus on transporter interactions","volume":"5","author":"N\u00f8hr","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.neuint.2019.02.015_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/add.13974","article-title":"Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate","volume":"113","author":"Palpacuer","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.neuint.2019.02.015_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF02584041","article-title":"alpha-Aminoadipic acid blocks the Na(+)-dependent glutamate transport into acutely isolated M\u00fcller glial cells from Guinea pig retina","volume":"429","author":"Pannicke","year":"1994","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuint.2019.02.015_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0005-2736(75)90347-8","article-title":"Kinetic analysis of blood-brain barrier transport of amino acids","volume":"401","author":"Pardridge","year":"1975","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2019.02.015_bib23","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2012"},{"key":"10.1016\/j.neuint.2019.02.015_bib24","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/epi.14032","article-title":"White matter spongiosis with vigabatrin therapy for infantile spasms","volume":"59","author":"Pearl","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuint.2019.02.015_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clineuro.2017.04.004","article-title":"Reduction of retinal nerve fiber layer thickness in vigabatrin-exposed patients: a meta-analysis","volume":"157","author":"Peng","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neuint.2019.02.015_bib26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/ana.410440614","article-title":"Vigabatrin increases human brain homocarnosine and improves seizure control","volume":"44","author":"Petroff","year":"1998","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.neuint.2019.02.015_bib102","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1528-1157.1999.tb00803.x","article-title":"Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures","volume":"40","author":"Petroff","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuint.2019.02.015_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0920-1211(98)00074-6","article-title":"Effects of vigabatrin treatment on status epilepticus-induced neuronal damage and mossy fiber sprouting in the rat hippocampus","volume":"33","author":"Pitk\u00e4nen","year":"1999","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuint.2019.02.015_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.etp.2014.09.004","article-title":"The effects of taurine on vigabatrin, high light intensity and mydriasis induced retinal toxicity in the pigmented rat","volume":"67","author":"Rasmussen","year":"2015","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.neuint.2019.02.015_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.1990.tb03772.x","article-title":"Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children","volume":"30","author":"Rey","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuint.2019.02.015_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/dmcn.12573","article-title":"Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study","volume":"57","author":"Riikonen","year":"2015","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuint.2019.02.015_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11910-008-0053-7","article-title":"New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7\/KCNQ\/M potassium channels","volume":"8","author":"Rogawski","year":"2008","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2019.02.015_bib32","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1111\/j.1365-2125.1989.tb03456.x","article-title":"Clinical pharmacology of vigabatrin","volume":"27","author":"Schechter","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Pt A","key":"10.1016\/j.neuint.2019.02.015_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2016.01.012","article-title":"A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: the UCLA experience","volume":"57","author":"Schwarz","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuint.2019.02.015_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1167\/iovs.10-6033","article-title":"Submacular DL-Alpha-Aminoadipic Acid Eradicates Primate Photoreceptors but Does Not Affect Luteal Pigment or the Retinal Vasculature","volume":"vol. 52","author":"Shen","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuint.2019.02.015_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2011.01606.x","article-title":"Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations","volume":"192","author":"Shields","year":"2011","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.neuint.2019.02.015_bib36","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1528-1157.2003.04203.x","article-title":"Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina","volume":"44","author":"Sills","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuint.2019.02.015_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eplepsyres.2010.08.006","article-title":"Is reduced ornithine-\u03b4-aminotransferase activity the cause of vigabatrin-associated visual field defects?","volume":"92","author":"Sorri","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuint.2019.02.015_bib38","series-title":"Neuroproteomics: Dissection of Rodent Brain Regions","first-page":"13","author":"Spijker","year":"2011"},{"key":"10.1016\/j.neuint.2019.02.015_bib39","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1073\/pnas.1237052100","article-title":"D-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors","volume":"100","author":"Stevens","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2019.02.015_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2045-8118-8-13","article-title":"Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders","volume":"8","author":"Tachikawa","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neuint.2019.02.015_bib41","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1113\/jphysiol.2013.253179","article-title":"Independent control of reciprocal and lateral inhibition at the axon terminal of retinal bipolar cells","volume":"591","author":"Tanaka","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuint.2019.02.015_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1159\/000453143","article-title":"The vigabatrin induced retinal toxicity is associated with photopic exposure and taurine deficiency: an in vivo study","volume":"40","author":"Tao","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuint.2019.02.015_bib43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/epi.12950","article-title":"The anticonvulsant retigabine is a subtype selective modulator of GABAA receptors","volume":"56","author":"Treven","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuint.2019.02.015_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/0004-282x20170192","article-title":"Globus pallidus restricted diffusion associated with vigabatrin therapy","volume":"76","author":"Trindade","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.neuint.2019.02.015_bib45","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s10072-017-2971-0","article-title":"Evaluation of inner retinal layers with optic coherence tomography in vigabatrin-exposed patients","volume":"38","author":"Tu\u011fcu","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuint.2019.02.015_bib46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1528-1157.1996.tb00655.x","article-title":"Treatment with vigabatrin may mimic alpha-aminoadipic aciduria","volume":"37","author":"Vallat","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuint.2019.02.015_bib47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0883073818768309","article-title":"Vigabatrin for epileptic spasms and tonic seizures in tuberous sclerosis complex","volume":"33","author":"van der Poest Clement","year":"2018","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuint.2019.02.015_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10545-012-9524-8","article-title":"Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice","volume":"36","author":"Vogel","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuint.2019.02.015_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pediatrneurol.2016.09.016","article-title":"mTOR inhibition mitigates molecular and biochemical alterations of vigabatrin-induced visual field toxicity in mice","volume":"66","author":"Vogel","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuint.2019.02.015_bib50","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cpt.581","article-title":"Aberrant mTOR signaling and disrupted autophagy: the missing link in potential vigabatrin-associated ocular toxicity?","volume":"101","author":"Vogel","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2019.02.015_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10545-016-9984-3","article-title":"Multicompartment analysis of protein-restricted phenylketonuric mice reveals amino acid imbalances in brain","volume":"40","author":"Vogel","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2019.02.015_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.456","article-title":"Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects","volume":"7","author":"Walters","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.neuint.2019.02.015_bib53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00702-009-0186-0","article-title":"Elevated endogenous GABA concentration attenuates glutamate-glutamine cycling between neurons and astroglia","volume":"116","author":"Yang","year":"2009","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2019.02.015_bib54","article-title":"Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2019.02.015_bib55","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cne.20416","article-title":"Nitric oxide stimulates gamma-aminobutyric acid release and inhibits glycine release in retina","volume":"483","author":"Yu","year":"2005","journal-title":"J. Comp. Neurol."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701861930066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701861930066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T11:43:47Z","timestamp":1565178227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019701861930066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":57,"alternative-id":["S019701861930066X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2019.02.015","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic analyses of vigabatrin (VGB)-treated mice: GABA-transaminase inhibition significantly alters amino acid profiles in murine neural and non-neural tissues","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2019.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}